Average Co-Inventor Count = 4.00
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Shire Human Genetic Therapies, Inc. (3 from 86 patents)
2. Translate Bio, Inc. (2 from 155 patents)
3. Takeda Pharmaceutical Company Limited (1 from 1,181 patents)
6 patents:
1. 12268754 - Composition and methods for treatment of ornithine transcarbamylase deficiency
2. 11357832 - Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
3. 11167043 - Composition and methods for treatment of ornithine transcarbamylase deficiency
4. 10578624 - Determination of glycosaminoglycan levels by mass spectrometry
5. 10568941 - Treatment of cognitive impairment of Hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
6. 9682129 - Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase